Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheuk S Kwok

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|January 4, 2014
Using a single parameter to describe time-activity curvesCheuk S Kwok, Paul H Frankel, George Lopatin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancerJeffrey Y C Wong, David Z Chu, Lawrence E Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancerJeffrey Y C Wong, Stephen Shibata, Lawrence E Williams, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancer Biotherapy & Radiopharmaceuticals|January 4, 2014
Using a single parameter to describe time-activity curvesCheuk S Kwok, Paul H Frankel, George Lopatin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancerJeffrey Y C Wong, David Z Chu, Lawrence E Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancerJeffrey Y C Wong, Stephen Shibata, Lawrence E Williams, et al.
Pageof 1